Copyright
©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 2012-2016
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2012
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2012
Table 1 Clinical data for patients with HBV and/or HCV infection
Group BC | Group B | Group C | Statistical value | |
Number of patients | 40 | 16 | 31 | |
Sex (male/female) | 21/19 | 6/10 | 15/16 | χ2 = 1.030, P > 0.05 |
Age (y)a | 39 ± 5 (29-50) | 40 ± 6 (31-53) | 39 ± 3 (32-44) | F = 0.48, P > 0.05 |
Time of infection (y)a | 16 ± 5 (14-21) | 16 ± 5 (14-21) | 17 ± 4 (14-21) | F = 2.27, P > 0.05 |
Serological markers (1994) | ||||
HBsAg + | 34 (85.0%) | 16 (100%) | 0 | |
HBeAg + | 11 (27.5%) | 7 (43.8%) | 0 | |
HBVDNA + | 37 (92.5%) | 14 (87.5%) | 0 | |
HCVRNA + | 11 (27.5%) | 0 (0%) | 19 (61.3%) | |
Anti-HCV | 39 (97.5%) | 0 (0%) | 31 (100.0%) |
Table 2 Clearance of serum HBV markers in Group BC and Group B
Group BC (n = 40, %) | Group B (n = 16, %) | |
HBsAg clearance | ||
Until 1994 | 6 (15%) | 0 (0%) |
Until 2002 | 27 (67.5%) | 8 (50%) |
HBeAg clearance/seroconversion | ||
HBeAg clearance | ||
Until 1994 | 29 (72.5%) | 10 (62.5%) |
Until 2002 | 37 (92.5%) | 14 (87.5%) |
HBeAg seroconversion | 22 (55.5%) | 12 (75%) |
HBV DNA clearance | ||
Until 1994 | 3 (7.5%) | 2 (12.5%) |
Until 2002 | 35 (87.5%) | 13 (81.2%) |
HBV clearance | 27 (67.5%) | 7 (43.8%) |
Male | 18 (85.7%)a | 4 (66.7%) |
Female | 9 (47.4%)b | 3 (30%) |
Low HBV DNA level group (< 105 copies/mL) | 17 (70.8%) | 4 (57.1%) |
High HBV DNA level group (≥ 105 copies/mL) | 10 (62.5%) | 3 (33.3%) |
Table 3 HCV RNA clearance rate in Group BC and Group C
Group BC (n = 40, %) | Group C (n = 31, %) | Statistics value | |
HCV RNA clearance | |||
Until 1994 | 29 (72.5%)a | 12 (38.7%)b | χ2 = 8.173, (a vs. b) P < 0.05 |
Until 2002 | 35 (87.5%)c | 10 (32.3%)d | χ2 = 22.963, (c vs. d) P < 0.001 |
Male | 17 (80.9%) | 3 (20%) | |
Female | 18 (94.7%) | 7 (43.8%) |
Table 4 Relationship of serum HBV and HCV load in 1994
HCV RNA (copies/mL) | HBV DNA(copies/mL) | Total amount | ||
< 103 | 103-105 | ≥ 105 | ||
< 103 | 2 | 14 | 12 | 28 |
103-105 | 1 | 5 | 3 | 9 |
≥ 105 | 0 | 2 | 1 | 3 |
Total amount | 3 | 21 | 16 | 40 |
Table 5 Type B ultrasonic presentations in patients with HBV and/or HCV infection
Normal | Mild | Medium | Severe | Fatty liver | Not detected | Total | |
Group BC | 4 | 0 | 2 | 1 | 3 | 30 | 10 |
Group B | 8 | 0 | 2 | 0 | 3 | 3 | 13 |
Group C | 0 | 13 | 14 | 1 | 2 | 1 | 31 |
- Citation: Fan CL, Wei L, Jiang D, Chen HS, Gao Y, Li RB, Wang Y. Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area. World J Gastroenterol 2003; 9(9): 2012-2016
- URL: https://www.wjgnet.com/1007-9327/full/v9/i9/2012.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i9.2012